A Fatty Acids Study in Preventing Retinopathy of Prematurity
NCT02760472
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Retinopathy of Prematurity
Interventions
DRUG:
SMOFlipid
DRUG:
Clinoleic
Sponsor
Carola Pfeiffer-Mosesson